XML 47 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Marketable Securities
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

3. Marketable Securities

 

A summary of the Company’s cash equivalents and marketable securities as of December 31, 2022 and 2021, which are recorded at fair value (and excludes $159.3 million and $405.6 million of cash at December 31, 2022 and 2021, respectively) is shown below (in thousands):

 

December 31, 2022

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

17,766

 

 

$

 

 

$

 

 

$

17,766

 

Corporate debt securities

 

 

2,151

 

 

 

 

 

 

(2

)

 

 

2,149

 

Certificates of deposit

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

32,675

 

 

 

 

 

 

 

 

 

32,675

 

Total cash equivalents

 

 

52,592

 

 

 

 

 

 

(2

)

 

 

52,590

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

1,236,770

 

 

 

615

 

 

 

(15,006

)

 

 

1,222,379

 

Certificates of deposit

 

 

92,417

 

 

 

 

 

 

 

 

 

92,417

 

Government-sponsored enterprise securities

 

 

79,746

 

 

 

11

 

 

 

(712

)

 

 

79,045

 

Commercial paper

 

 

263,231

 

 

 

 

 

 

(509

)

 

 

262,722

 

Total marketable securities

 

 

1,672,164

 

 

 

626

 

 

 

(16,227

)

 

 

1,656,563

 

Total cash equivalents and marketable securities

 

$

1,724,756

 

 

$

626

 

 

$

(16,229

)

 

$

1,709,153

 

 

December 31, 2021

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

507,386

 

 

$

 

 

$

 

 

$

507,386

 

Corporate debt securities

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

9,997

 

 

 

 

 

 

(1

)

 

 

9,996

 

Total cash equivalents

 

 

517,383

 

 

 

 

 

 

(1

)

 

 

517,382

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

16,238

 

 

 

6

 

 

 

(52

)

 

 

16,192

 

Corporate debt securities

 

 

1,173,659

 

 

 

10

 

 

 

(4,903

)

 

 

1,168,766

 

Certificates of deposit

 

 

45,164

 

 

 

 

 

 

 

 

 

45,164

 

Government-sponsored enterprise securities

 

 

13,334

 

 

 

 

 

 

(77

)

 

 

13,257

 

Commercial paper

 

 

212,805

 

 

 

 

 

 

(86

)

 

 

212,719

 

Total marketable securities

 

 

1,461,200

 

 

 

16

 

 

 

(5,118

)

 

 

1,456,098

 

Total cash equivalents and marketable securities

 

$

1,978,583

 

 

$

16

 

 

$

(5,119

)

 

$

1,973,480

 

 

As of December 31, 2022 and 2021, the aggregate fair value of marketable securities that were in an unrealized loss position for less than twelve months was $628.4 million and $1,311.6 million, respectively. As of December 31, 2022 and 2021, the aggregate fair value of marketable securities that were in an unrealized loss position for more than twelve months was $619.2 million and $4.6 million, respectively. Of this amount, securities totaling $53.1 million as of December 31, 2022 will mature beyond one year. No securities in an unrealized loss position for more than twelve months as of December 31, 2021 will mature beyond one year. The Company has recorded a net unrealized loss of $10.5 million and $5.0 million, respectively, during the years ended December 31, 2022 and 2021 related to its marketable securities, which is included in comprehensive (loss) income on the consolidated statements of operations and comprehensive (loss) income.

 

The Company determined that there was no material credit risk of the above investments as of December 31, 2022 and 2021. The Company has the intent and ability to hold such securities until recovery. As a result, the Company did not record any charges for credit-related impairments for its marketable securities for the years ended December 31, 2022 and 2021. No available-for-sale debt securities held as of December 31, 2022 had remaining maturities greater than thirty months.